PharmiWeb.com - Global Pharma News & Resources
01-Jul-2019

Left Ventricular Assist Device Treatment Market to Hit USD 2,043 Mn by 2024 with Accelerate CAGR 10.5%

The Global Left Ventricular Assist Device Treatment Market is expected to grow significantly from USD 1,024 million in 2017 to USD 2,043 million in 2024, at a accelerate CAGR of 10.5% from 2018 to 2024.

The Global Left Ventricular Assist Device Treatment Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2024. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2024.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/12349

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the Global Left Ventricular Assist Device Treatment Market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

What is the market size in 2018 and the growth rate of the Global Left Ventricular Assist Device Treatment Market?

What is the market drivers, restrains, opportunities governing the Global Left Ventricular Assist Device Treatment Market?

Which are the largest and the fastest growing segments in the Global Left Ventricular Assist Device Treatment Market?

Who are the key players operating in the market and their market position?

What is the pipeline scenario, drug pricing analysis and technological development in the market?

View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market-report/global-left-ventricular-assist-device-treatment-market-emr-12349

The key factor propelling the growth of the global left ventricular assist device (LVADs) market is increasing prevalence of heart failure coupled with limitation of suitable organ donors. Additionally, growing number of devices and therapy approvals, along with technological advancements in product design is further boosting the growth of the global left ventricular assist device market. The years used for the assessment are as follows;

Historical year: 2014, 2015, 2016

Base year: 2017

Forecast period: 2018 ndash; 2024

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
Interacting with key opinion leaders of the market and developing data points based on interaction with them
Study of past trends in the market and their year on year Impact on the market size and share
Analyzing the collected data points
Bridging the data points to calculate the total global left ventricular assist device market and its various segments
Anticipating potential risks
Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global left ventricular assist device market
Finalizing the overall size and share of the global left ventricular assist device market

OBJECTIVES:

To analyze market trends, opportunities, drivers, and restraints associated with the left ventricular assist device market
To study market response with respect to the mergers and acquisitions in the industry
To profile key companies operating in the left ventricular assist device market and provide their competitive landscape

MARKET SCOPE

The research scope for Left Ventricular Assist Device Market is as follows:

By Type of Indication
Destination therapy
Bridge to transplantation
Bridge to recovery
Bridge to destination

By End-User
Hospitals
Cardiology Centers

By Region
North America
Latin America
Europe
Asia-Pacific
Middle East and Africa

FREE ANALYSIS

The global left ventricular assist device (LVADs) market is expected to grow significantly from USD 1,024 million in 2017 to USD 2,043 million in 2024, at a CAGR of 10.5% from 2018 to 2024. The key factor propelling the growth of the global left ventricular assist device (LVADs) market is increasing prevalence of heart failure coupled with limitation of suitable organ donors. Additionally, growing number of devices and therapy approvals, along with technological advancements in product design is further boosting the growth of the global left ventricular assist device market. However, high cost associated with the implantation may hinder the growth of the market to some extent.

On the basis of Type of Indication:

The bridge to transplantation segment holds the largest share of the global LVADs market in 2017 and is expected to grow at a significant rate during the forecast period owing to larger number of devices available for use as bridge-to-transplantation
The destination therapy, segment is expected to be the fastest growing segment of the global LVADs market in 2017
Geographically, North America holds the major share of the global LVADs market in 2017, owing to the growing number of heart failure patients, and shortage of organ donors in the region. Furthermore, favorable government policies, and adoption of new technologies is also driving the growth in the North American LVADs market. Asia-Pacific region is expected to witness fastest growth rate during the forecast period, owing to increasing incidence of cardiovascular diseases, and growing number of elderly patients. Growth of left ventricular assist device market in Europe is mainly due to European regulatory approval for the introduction of new medical devices.

Key players profiled in the global LVADs market are Abbott Laboratories, Abiomed, Berlin Heart Gmbh, Thoratec Corporation, Jarvik Heart Inc., Heart Ware International Inc., Apaxis, Inc., CorWave, Evaheart, Inc., and St Jude Medical, Reliantheart.

Table Of Contents

Global Left Ventricular Assist Device Treatment Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation amp; Forecast 2024

CHAPTER 1. Market Scope and Methodology

1.1. Market Definition

1.2. Market Segmentation

1.2.1. Market Breakdown, By Types of Indication

1.2.2. Market Breakdown, By End-User

1.2.3. Market Breakdown, By Region

1.3. Research Methodology

1.3.1. Initial Data Search

1.3.2. Secondary Research

1.3.3. Primary Research

1.3.4. Scope and Assumptions

1.4. Sources

1.5. Executive Summary

CHAPTER 2. Market Outlook

2.1. Introduction

2.2. Market Outlook

2.2.1. Opportunities

2.2.1.1. Development of more advance LVADs

2.2.2. Trends

2.2.2.1. Ongoing clinical trials of left ventricular assist devices for patient with advance heart failure

2.2.3. Growth Drivers

2.2.3.1. Rising prevalence of cardiovascular diseases

2.2.3.2. Technological advancements in product design

2.2.4. Impact Analysis of Drivers on Future Forecast of the Market

2.2.5. Restraints of the Market

2.2.5.1. High cost associated with LVADs

2.2.6. Impact Analysis of Restraints on Future Forecast of the Market

CHAPTER 3. Market Entry Strategy

3.1. Value Chain Analysis

3.2. Competitive Analysis

3.2.1. Company Market Share Analysis

3.2.2. Porterrsquo;s Five Forces Analysis

CHAPTER 4. Global Left Ventricular Assist Devices (LVADs) Market Size and Forecast (2014 ndash; 2024)

4.1. Global Left Ventricular Assist Devices (LVADs) Market, By Types of Indication

4.1.1. Destination Therapy

4.1.2. Bridge to Transplantation

4.1.3. Bridge to Recovery

4.1.4. Bridge to Destination

4.2. Global Left Ventricular Assist Devices (LVADs) Market, By End-User

4.2.1. Hospitals

4.2.2. Cardiology Centers

4.3. Global Left Ventricular Assist Devices (LVADs) Market, By Region

4.3.1. North America

4.3.2. Latin America

4.3.3. Europe

4.3.4. Asia-Pacific

4.3.5. Middle East and Africa

CHAPTER 5. Global Left Ventricular Assist Devices (LVADs) Market, By Geography

5.1. North America Left Ventricular Assist Devices (LVADs) Market

5.1.1. North America Left Ventricular Assist Devices (LVADs) Market, By Types of Indication (USD Million)

5.1.2. North America Left Ventricular Assist Devices (LVADs) Market, By End-User (USD Million)

5.1.3. North America Left Ventricular Assist Devices (LVADs) Market, By Country

5.1.3.1. The U.S.

5.1.3.2. Canada

5.1.3.3. Mexico

5.2. Latin America Left Ventricular Assist Devices (LVADs) Market

5.2.1. Latin America Left Ventricular Assist Devices (LVADs) Market, By Types of Indication (USD Million)

5.2.2. Latin America Left Ventricular Assist Devices (LVADs) Market, By End-User (USD Million)

5.2.3. Latin America Left Ventricular Assist Devices (LVADs) Market, By Country

5.2.3.1. Argentina

5.2.3.2. Brazil

5.2.3.3. Colombia

5.2.3.4. Rest of Latin America

5.2.3.4.1. Rest of Latin America Left Ventricular Assist Devices (LVADs) Market, By Types of Indication (USD Million)

5.2.3.4.2. Rest of Latin America Left Ventricular Assist Devices (LVADs) Market, By End-User (USD Million)

5.3. Europe Left Ventricular Assist Devices (LVADs) Market

5.3.1. Europe Left Ventricular Assist Devices (LVADs) Market, By Types of Indication (USD Million)

5.3.2. Europe Left Ventricular Assist Devices (LVADs) Market, By End-User (USD Million)

5.3.3. Europe Left Ventricular Assist Devices (LVADs) Market, By Country

5.3.3.1. Germany

5.3.3.2. France

5.3.3.3. The U.K.

5.3.3.4. Italy

5.3.3.5. Spain

5.3.3.6. France

5.3.3.7. Monaco

5.3.3.8. Estonia

5.3.4. Rest of Europe

5.3.4.1. Rest of Europe Left Ventricular Assist Devices (LVADs) Market, By Types of Indication (USD Million)

5.3.4.2. Rest of Europe Left Ventricular Assist Devices (LVADs) Market, By End-User (USD Million)

5.4. Asia-Pacific Left Ventricular Assist Devices (LVADs) Market

5.4.1. Asia-Pacific Left Ventricular Assist Devices (LVADs) Market, By Types of Indication (USD Million)

5.4.2. Asia-Pacific Left Ventricular Assist Devices (LVADs) Market, By End-User (USD Million)

5.4.3. Asia-Pacific Left Ventricular Assist Devices (LVADs) Market, By Country

5.4.3.1. China

5.4.3.2. Japan

5.4.3.3. Singapore

5.4.3.4. Australia

5.4.3.5. India

5.4.3.6. South Korea

5.4.3.7. New Zealand

5.4.3.8. Rest of Asia-Pacific

5.4.3.8.1. Rest of Asia-Pacific Left Ventricular Assist Devices (LVADs) Market, By Types of Indication (USD Million)

5.4.3.8.2. Rest of Asia-Pacific Left Ventricular Assist Devices (LVADs) Market, By End-User (USD Million)

5.5. Middle East and Africa Left Ventricular Assist Devices (LVADs) Market

5.5.1. Middle East and Africa Left Ventricular Assist Devices (LVADs) Market, By Types of Indication (USD Million)

5.5.2. Middle East and Africa Left Ventricular Assist Devices (LVADs) Market, By End-User (USD Million)

5.5.3. Middle East and Africa Left Ventricular Assist Devices (LVADs) Market, By Country

5.5.3.1. Israel

5.5.3.2. Saudi Arabia

5.5.3.3. Ethiopia

5.5.3.4. Iran

5.5.3.5. Rest of Middle East and Africa

5.5.3.5.1. Rest of Middle East and Africa Left Ventricular Assist Devices (LVADs) Market, By Types of Indication (USD Million)

5.5.3.5.2. Rest of Middle East and Africa Left Ventricular Assist Devices (LVADs) Market, By End-User (USD Million)

CHAPTER 6. Key Players and Strategic Developments

6.1. Abbott Laboratories

6.1.1. Business Overview

6.1.2. Product and Service Offering

6.1.3. Financial Overview

6.1.4. SWOT Analysis

6.1.5. Strategic Developments

6.2. Abiomed

6.2.1. Business Overview

6.2.2. Product and Service Offering

6.2.3. Financial Overview

6.2.4. SWOT Analysis

6.2.5. Strategic Developments

6.3. Berlin Heart Gmbh

6.3.1. Business Overview

6.3.2. Product and Service Offering

6.3.3. Financial Overview

6.3.4. SWOT Analysis

6.3.5. Strategic Developments

6.4. Thoratec Corporation

6.4.1. Business Overview

6.4.2. Product and Service Offering

6.4.3. Financial Overview

6.4.4. SWOT Analysis

6.4.5. Strategic Developments

6.5. Jarvik Heart Inc.

6.5.1. Business Overview

6.5.2. Product and Service Offering

6.5.3. Financial Overview

6.5.4. SWOT Analysis

6.5.5. Strategic Developments

6.6. Heart Ware International Inc.

6.6.1. Business Overview

6.6.2. Product and Service Offering

6.6.3. Financial Overview

6.6.4. SWOT Analysis

6.6.5. Strategic Developments

6.7. Apaxis, Inc.

6.7.1. Business Overview

6.7.2. Product and Service Offering

6.7.3. Financial Overview

6.7.4. SWOT Analysis

6.7.5. Strategic Developments

6.8. CorWave

6.8.1. Business Overview

6.8.2. Product and Service Offering

6.8.3. Financial Overview

6.8.4. SWOT Analysis

6.8.5. Strategic Developments

6.9. Evaheart, Inc.

6.9.1. Business Overview

6.9.2. Product and Service Offering

6.9.3. Financial Overview

6.9.4. SWOT Analysis

6.9.5. Strategic Developments

6.10. St Jude Medical

6.10.1. Business Overview

6.10.2. Product and Service Offering

6.10.3. Financial Overview

6.10.4. SWOT Analysis

6.10.5. Strategic Developments

6.11. Reliantheart

6.11.1. Business Overview

6.11.2. Product and Service Offering

6.11.3. Financial Overview

6.11.4. SWOT Analysis

6.11.5. Strategic Development

6.12. Abbreviation

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/12349

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Email: sales@amecoresearch.com | +1 407 915 4157

Editor Details

Last Updated: 01-Jul-2019